YouScript and Grane Rx Partner to Reduce Adverse Drug Events Using Pharmacogenetics for PACE Industry

YouScript will be available to all independent PACE organizations utilizing Grane Rx’s PACE pharmacy solutions.

This technology solution will offer another layer of protection to help prevent adverse drug events and avoidable hospitalizations among PACE participants. This, in turn, can also result in cost savings for the PACE centers themselves.

YouScript and Grane Rx announce today an agreement to deliver precision prescribing support to PACE (Program for All-Inclusive Care for the Elderly) organizations.

Adverse drug events (ADEs) are a leading cause of avoidable hospitalization among the senior population. Each year, these events claim more than 100,000 lives and cause more than 700,000 emergency department visits. The vast majority of ADEs are caused by medications prescribed according to best practice guidelines.[1]

That’s because traditional prescribing best practices don’t take into account the different ways that individual participants react to medications. Enter Grane Rx’s Medication Insights™, powered by YouScript.

Utilizing a proprietary Risk Analysis dashboard, prescribers are alerted in real-time as to which participants are most vulnerable to significant medication-related problems. Potential issues are identified within the software, and providers are able to view and select alternative medications both within the drug class and for a specific therapeutic indication.

“The FDA has stated in drug development guidance that drug-gene interactions are as significant as drug-drug interactions,” said Kristine Ashcraft, Chief Executive Officer at YouScript. “I applaud Grane Rx for taking the lead to integrate this key information into medication management for our most vulnerable seniors.”

Recent studies[2] in the home health environment showed that using YouScript can save approximately $4,382 per patient over a 60-day period, in addition to reducing hospitalizations and readmission rates by 52 percent and 42 percent respectively. For a PACE organization that have 250 participants, this patented technology could generate a significant amount of savings just based upon the results of the study.    

“Polypharmacy is a major challenge for PACE organizations and their participants,…

Read the full article from the Source…

Leave a Reply

Your email address will not be published. Required fields are marked *